Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Centessa Pharmaceuticals (CNTA) Gross Profit: 2022-2024

Historic Gross Profit for Centessa Pharmaceuticals (CNTA) over the last 3 years, with Dec 2024 value amounting to -$10.1 million.

  • Centessa Pharmaceuticals' Gross Profit fell 13.02% to -$2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 166.27%. This contributed to the annual value of -$10.1 million for FY2024, which is 247.23% down from last year.
  • Per Centessa Pharmaceuticals' latest filing, its Gross Profit stood at -$10.1 million for FY2024, which was down 247.23% from $6.9 million recorded in FY2023.
  • In the past 5 years, Centessa Pharmaceuticals' Gross Profit registered a high of $6.9 million during FY2023, and its lowest value of -$10.1 million during FY2024.
  • In the last 3 years, Centessa Pharmaceuticals' Gross Profit had a median value of -$7.3 million in 2022 and averaged -$3.5 million.
  • As far as peak fluctuations go, Centessa Pharmaceuticals' Gross Profit surged by 194.17% in 2023, and later crashed by 247.23% in 2024.
  • Yearly analysis of 3 years shows Centessa Pharmaceuticals' Gross Profit stood at -$7.3 million in 2022, then surged by 194.17% to $6.9 million in 2023, then crashed by 247.23% to -$10.1 million in 2024.